HQ Function

Serves as the company's primary center for research and development operations, clinical development strategy, and corporate administration.

Notable Features:

Strategically located in a key biotechnology hub, likely equipped with modern laboratory spaces and collaborative environments conducive to cutting-edge scientific discovery and drug development.

Work Culture:

Fosters a science-driven, innovative, and collaborative work environment. The culture likely emphasizes teamwork, scientific rigor, and a strong commitment to advancing therapies for patients with cancer.

HQ Significance:

The San Francisco Bay Area location provides critical access to a rich ecosystem of top-tier scientific talent, renowned academic and research institutions, and a strong network of investors and potential partners.

Values Reflected in HQ: The headquarters' focus on advanced research and development capabilities mirrors the company's core values of scientific excellence, innovation, and a patient-centric approach to developing new cancer treatments.

Location:

While headquartered in the United States, Immuno-Onc Therapeutics has a global reach through its clinical trial activities, which may involve sites in various countries. The company also engages with the international scientific community through research collaborations and participation in global oncology conferences. Their ultimate aim is to develop therapies that can benefit cancer patients worldwide.

Street Address:

953 Indiana Street

City:

San Francisco

State/Province:

California

Country:

USA